These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6356462)

  • 21. Effects of ticlopidine on platelet prostaglandin metabolism. Possible consequences for prostacyclin production.
    Lagarde M; Ghazi I; Dechavanne M
    Prostaglandins Med; 1979 Jun; 2(6):433-9. PubMed ID: 399526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of ticlopidine administration to humans on the binding of adenosine diphosphate to blood platelets.
    Lips NP; Sixma JJ; Schiphorst ME
    Thromb Res; 1980 Jan 1-15; 17(1-2):19-27. PubMed ID: 7376129
    [No Abstract]   [Full Text] [Related]  

  • 23. Platelet aggregation measured in rabbit whole blood: in vitro study of 3 aggregating agents and ex vivo inhibition by aspirin and ticlopidine.
    Chevolet C; Grosdent JC; Reiters GM; Dresse A
    Arch Int Pharmacodyn Ther; 1982 Oct; 259(2):310-1. PubMed ID: 6817725
    [No Abstract]   [Full Text] [Related]  

  • 24. In vivo effect of ticlopidine on fibrinogen-platelet cofactor activity and binding of fibrinogen to platelets.
    Dunn FW; Soria J; Soria C; Thomaidis A; Lee H; Caen JP
    Agents Actions Suppl; 1984; 15():97-104. PubMed ID: 6091425
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of 5-(2-chlorobenzyl)-5,6,7,7a-tetrahydro 4H-thieno (3.2-C)-pyridine-2-one hydrochloride (PCR 3787), a metabolite of ticlopidine, on the aggregation of human platelets in vitro and on the aggregation inhibiting action of PGI2 and PGD2.
    Vincent JE; Zijlstra FJ; de Wit CM; Bonta IL
    Prostaglandins Leukot Med; 1984 Dec; 16(3):279-83. PubMed ID: 6396655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of ticlopidine on platelet aggregation, adherence to damaged vessels, thrombus formation and platelet survival.
    Cattaneo M; Winocour PD; Somers DA; Groves HM; Kinlough-Rathbone RL; Packham MA; Mustard JF
    Thromb Res; 1985 Jan; 37(1):29-43. PubMed ID: 3983900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ticlopidine as an experimental antithrombotic agent.
    Vallée E; Maffrand JP; Bernat A; Delebassée D; Tissinier A
    Agents Actions Suppl; 1984; 15():50-9. PubMed ID: 6592945
    [No Abstract]   [Full Text] [Related]  

  • 28. Fusaric acid, a mycotoxin, and its influence on blood coagulation and platelet function.
    Devaraja S; Girish KS; Santhosh MS; Hemshekhar M; Nayaka SC; Kemparaju K
    Blood Coagul Fibrinolysis; 2013 Jun; 24(4):419-23. PubMed ID: 23343693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of ticlopidine on canine platelets, fibrinogen, and antithrombin III activity.
    Boudreaux MK; Jeffers C; Lipscomb D; Spano JS
    J Vet Pharmacol Ther; 1992 Mar; 15(1):1-9. PubMed ID: 1573697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet activation induced by a human neuroblastoma tumor cell line is reduced by prior administration of ticlopidine.
    Bastida E; Escolar G; Almirall L; Ordinas A
    Thromb Haemost; 1986 Jun; 55(3):333-7. PubMed ID: 3750263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacodynamic and pharmacokinetic evaluation of clopidogrel and the carboxylic acid metabolite SR 26334 in healthy dogs.
    Brainard BM; Kleine SA; Papich MG; Budsberg SC
    Am J Vet Res; 2010 Jul; 71(7):822-30. PubMed ID: 20594086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of ticlopidine on human platelet responsiveness ex vivo: comparison with aspirin.
    Nunn B; Lindsay R
    Thromb Res; 1980 Jun; 18(6):807-813. PubMed ID: 7414564
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacokinetic and metabolic characteristics of ticlopidine in relation to its inhibitory properties on platelet function.
    Picard-Fraire C
    Agents Actions Suppl; 1984; 15():68-75. PubMed ID: 6385655
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibition by ticlopidine of Paf-acether-induced in vitro aggregation of rabbit and human platelets.
    Lalau Keraly C; Delautier D; Delabassee D; Chignard M; Benveniste J
    Thromb Res; 1984 Jun; 34(6):463-71. PubMed ID: 6740569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
    Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T
    Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of suprofen, an inhibitor of prostaglandin biosynthesis, on platelet function, plasma coagulation and fibrinolysis II. In vivo experiments.
    De Clerck F; Vermylen J; Reneman R
    Arch Int Pharmacodyn Ther; 1975 Sep; 217(1):68-79. PubMed ID: 1190914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiplatelet and antithrombotic effects of a combination of ticlopidine and ginkgo biloba ext (EGb 761).
    Kim YS; Pyo MK; Park KM; Park PH; Hahn BS; Wu SJ; Yun-Choi HS
    Thromb Res; 1998 Jul; 91(1):33-8. PubMed ID: 9700851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet-dependent granulocyte activation in vitro: effect of ticlopidine.
    Laghi Pasini F; Ceccatelli L; Pasqui AL; Orrico A; Capecchi PL; Di Perri T
    Int J Tissue React; 1985; 7(5):367-72. PubMed ID: 2997067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of suloctidil on bleeding time and in vivo platelet aggregation in rats.
    de Gaetano G; Cavenaghi AE
    Thromb Res; 1977 Mar; 10(3):525-30. PubMed ID: 854885
    [No Abstract]   [Full Text] [Related]  

  • 40. Antithrombotic effects of ticlopidine, acetylsalicyclic acid and dipyridamole in vascular shunt model in rats.
    Ashida S; Sakuma K; Abiko Y
    Thromb Res; 1980 Mar; 17(5):663-71. PubMed ID: 7385100
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.